Less invasive beractant administration in preterm infants: a pilot study

Cristina Ramos-Navarro, Manuel Sánchez-Luna, Susana Zeballos-Sarrato, Noelia González-Pacheco, Cristina Ramos-Navarro, Manuel Sánchez-Luna, Susana Zeballos-Sarrato, Noelia González-Pacheco

Abstract

Objectives: The aims of this study were to assess the efficacy and feasibility of a new, less invasive surfactant administration technique for beractant replacement using a specifically designed cannula in preterm infants born at <32 weeks of gestation and to compare short- and long-term outcomes between this approach and standard treatment, consisting of intubation, administration of surfactant and early extubation to nasal continuous positive airway pressure.

Method: This was a single-center, prospective, open-label, non-randomized, controlled pilot study with an experimental cohort of 30 patients treated with less invasive surfactant administration and a retrospective control group comprising the 30 patients most recently treated with the standard approach. Beractant (4 ml/kg) was administered as an exogenous surfactant in both groups if patients on nasal continuous positive airway pressure during the first three days of life were in need of more than 30% FiO2. Clinicaltrials.gov: NCT02611284.

Results: In the group with less invasive surfactant administration, beractant was successfully administered in all patients. Thirteen patients (43.3%) in the group with less invasive surfactant administration required invasive mechanical ventilation for more than 1 hour during the first 3 days of life, compared with 22 (73%) in the control group (p<0.036). The rate of requiring invasive mechanical ventilation for more than 48 hours was similar between the infants in the two groups (46% vs. 40%, respectively). There were no differences in other outcomes.

Conclusion: The administration of beractant (4 ml/kg) using a less invasive surfactant administration technique with a specifically designed cannula for administration is feasible. Moreover, early invasive mechanical ventilation exposure is significantly reduced by this method compared with the strategy involving intubation, surfactant administration and early extubation.

Conflict of interest statement

No potential conflict of interest was reported.

Figures

Figure 1-
Figure 1-
A 5-gauge French, gamma-sterilized, multi-access catheter specifically designed to deliver surfactants in neonates/pediatric patients.
Figure 2-
Figure 2-
Patients who needed intubation and invasive mechanical ventilation after less invasive surfactant administration or standard treatment.

References

    1. Polin RA, Carlo WA, Newborn CoFa, Pediatrics AAo. Surfactant replacement therapy for preterm and term neonates with respiratory distress. Pediatrics. 2014;133((1)):156–63.
    1. Sweet DG, Carnielli V, Greisen G, Hallman M, Ozek E, Plavka R, et al. European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants--2013 update. Neonatology. 2013;103((4)):353–68.
    1. Stevens TP, Harrington EW, Blennow M, Soll RF. Cochrane Database Syst Rev. (4) 2007. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome; p. CD003063.
    1. O'Donnell CP, Kamlin CO, Davis PG, Morley CJ. Endotracheal intubation attempts during neonatal resuscitation: success rates, duration, and adverse effects. Pediatrics. 2006;117((1)):e16–21.
    1. Committee on F, Newborn, American Academy of P. Respiratory support in preterm infants at birth. Pediatrics. 2014;133((1)):171–4.
    1. Carvalho CG, Silveira RC, Procianoy RS. Ventilator-induced lung injury in preterm infants. Rev Bras Ter Intensiva. 2013;25((4)):319–26.
    1. Verder H, Albertsen P, Ebbesen F, Greisen G, Robertson B, Bertelsen A, et al. Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks&apos; gestation. Pediatrics. 1999;103((2)):E24.
    1. Bohlin K, Gudmundsdottir T, Katz-Salamon M, Jonsson B, Blennow M. Implementation of surfactant treatment during continuous positive airway pressure. J Perinatol. 2007;27((7)):422–7.
    1. Kattwinkel J, Robinson M, Bloom BT, Delmore P, Ferguson JE. Technique for intrapartum administration of surfactant without requirement for an endotracheal tube. J Perinatol. 2004;24((6)):360–5.
    1. Trevisanuto D, Grazzina N, Ferrarese P, Micaglio M, Verghese C, Zanardo V. Laryngeal mask airway used as a delivery conduit for the administration of surfactant to preterm infants with respiratory distress syndrome. Biol Neonate. 2005;87((4)):217–20.
    1. Finer NN, Merritt TA, Bernstein G, Job L, Mazela J, Segal R. An open label, pilot study of Aerosurf&reg; combined with nCPAP to prevent RDS in preterm neonates. J Aerosol Med Pulm Drug Deliv. 2010;23((5)):303–9.
    1. Verder H, Agertoft L, Albertsen P, Christensen NC, Curstedt T, Ebbesen F, et al. [Surfactant treatment of newborn infants with respiratory distress syndrome primarily treated with nasal continuous positive air pressure. A pilot study] Ugeskr Laeger. 1992;154((31)):2136–9.
    1. Kribs A. Early administration of surfactant in spontaneous breathing with nCPAP through a thin endotracheal catheter--an option in the treatment of RDS in ELBW infants. J Perinatol. 2009;29((3)):256.
    1. Kribs A, Pillekamp F, Hünseler C, Vierzig A, Roth B. Early administration of surfactant in spontaneous breathing with nCPAP: feasibility and outcome in extremely premature infants (postmenstrual age &lt;/&equals;27 weeks) Paediatr Anaesth. 2007;17((4)):364–9.
    1. Kribs A. How best to administer surfactant to VLBW infants. 2011;96((4)):F238–40. Arch Dis Child Fetal Neonatal Ed.
    1. Dargaville PA, Aiyappan A, De Paoli AG, Kuschel CA, Kamlin CO, Carlin JB, et al. Minimally-invasive surfactant therapy in preterm infants on continuous positive airway pressure. 2013;98((2)):F122–6. Arch Dis Child Fetal Neonatal Ed.
    1. Aguar M, Nuñez A, Cubells E, Cernada M, Dargaville PA, Vento M. Administration of surfactant using less invasive techniques as a part of a non-aggressive paradigm towards preterm infants. Early Hum Dev. 2014;90(2):S57–9.
    1. Dargaville PA, Kamlin CO, De Paoli AG, Carlin JB, Orsini F, Soll RF, et al. The OPTIMIST-A trial: evaluation of minimally-invasive surfactant therapy in preterm infants 25-28 weeks gestation. BMC Pediatr. 2014;14:213.
    1. More K, Sakhuja P, Shah PS. Minimally invasive surfactant administration in preterm infants: a meta-narrative review. JAMA Pediatr. 2014;168((10)):901–8.
    1. Lopez E, Gascoin G, Flamant C, Merhi M, Tourneux P, Baud O, et al. Exogenous surfactant therapy in 2013: what is next? Who, when and how should we treat newborn infants in the future. BMC Pediatr. 2013;13:165.
    1. de Kort EH, Reiss IK, Simons SH. Sedation of newborn infants for the INSURE procedure, are we sure. Biomed Res Int. 2013;2013:892974.
    1. McPherson C. Sedation and analgesia in mechanically ventilated preterm neonates: continue standard of care or experiment. J Pediatr Pharmacol Ther. 2012;17((4)):351–64.
    1. McPherson C, Grunau RE. Neonatal pain control and neurologic effects of anesthetics and sedatives in preterm infants. Clin Perinatol. 2014;41((1)):209–27.
    1. Kanmaz HG, Erdeve O, Canpolat FE, Mutlu B, Dilmen U. Surfactant Administration via Thin Catheter During Spontaneous Breathing: Randomized Controlled Trial. Pediatrics. 2013;131((2)):e502–e9.
    1. Aguar M, Cernada M, Brugada M, Gimeno A, Gutierrez A, Vento M. Minimally invasive surfactant therapy with a gastric tube is as effective as the intubation, surfactant, and extubation technique in preterm babies. Acta Paediatr. 2014;103((6)):e229–33.
    1. Klebermass-Schrehof K, Wald M, Schwindt J, Grill A, Prusa AR, Haiden N, et al. Less invasive surfactant administration in extremely preterm infants: impact on mortality and morbidity. Neonatology. 2013;103((4)):252–8.
    1. Bohrer B, Silveira RC, Neto EC, Procianoy RS. Mechanical ventilation of newborns infant changes in plasma pro- and anti-inflammatory cytokines. J Pediatr. 2010;156((1)):16–9.
    1. Kribs A, Roll C, Gopel W, Wieg C, Groneck P, Laux R, et al. Nonintubated Surfactant Application vs Conventional Therapy in Extremely Preterm Infants: A Randomized Clinical Trial. JAMA Pediatr. 2015;169((8)):723–30.
    1. Bohlin K, Bouhafs RK, Jarstrand C, Curstedt T, Blennow M, Robertson B. Spontaneous breathing or mechanical ventilation alters lung compliance and tissue association of exogenous surfactant in preterm newborn rabbits. Pediatr Res. 2005;57(5 Pt 1)):624–30.
    1. Bjorklund LJ, Ingimarsson J, Curstedt T, John J, Robertson B, Werner O, et al. Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lambs. Pediatr Res. 1997;42((3)):348–55.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren